Copyright: ©Author(s) 2026.
World J Cardiol. May 26, 2026; 18(5): 120519
Published online May 26, 2026. doi: 10.4330/wjc.v18.i5.120519
Published online May 26, 2026. doi: 10.4330/wjc.v18.i5.120519
Figure 5 Cytokine levels released by human umbilical vein endothelial cells treated with oxidized low-density lipoprotein.
A: The interleukin-1β levels released by human umbilical vein endothelial cells treated with 25 μg/mL of oxidized low-density lipoprotein for 24 hours; B: The tumor necrosis factor-α levels released by human umbilical vein endothelial cells treated with 25 μg/mL of oxidized low-density lipoprotein for 24 hours. aP < 0.01 vs 0 μg/mL. IL: Interleukin; TNF-α: Tumor necrosis factor-α.
- Citation: Chu FY, Yao MH, Gu LM, Cai H, Li YN, Chen X, Xu XX. S1PR1 knockdown protects endothelial cells from oxidized low-density lipoprotein-induced injury via reducing interleukin-1β and tumor necrosis factor-α expression. World J Cardiol 2026; 18(5): 120519
- URL: https://www.wjgnet.com/1949-8462/full/v18/i5/120519.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i5.120519